Reuters logo
3 years ago
Roche to buy U.S. biotech firm Seragon for $725 million
July 2, 2014 / 5:20 AM / 3 years ago

Roche to buy U.S. biotech firm Seragon for $725 million

1 Min Read

ZURICH, July 2 (Reuters) - Roche said it will pay $725 million in cash to buy Seragon Pharmaceuticals, a privately-held biotech company which researches breast cancer treatments.

Basel-based drugmaker Roche said it could pay up to another $1 billion based on Seragon reaching certain milestones. (Reporting By Katharina Bart; Editing by Maria Sheahan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below